Purging iron from the heart
- 19 April 2004
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 125 (5) , 545-551
Abstract
Summary: Methods are now available to measure the magnitude of iron accumulation in the heart. Their validation currently relies on indirect evidence and not on chemical estimation in cardiac biopsies. All patients with symptomatic heart disease appear to have abnormal T2* values, but many patients without symptomatic heart disease also have evidence of increased myocardial iron. Although there is no proof to date that increased myocardial iron, as evidenced by abnormal magnetic resonance imaging, carries an adverse prognosis, it is likely that such new information will affect the chelating programme of patients. In these cases, there are a number of options available: (i) ongoing treatment with either desferrioxamine (DFO) or deferiprone may be intensified; (ii) the patient may be switched to the alternative chelator or (iii) combined chelation with both DFO and deferiprone may be started, which is more effective than using either chelator alone. For patients with symptomatic heart disease, continuous intravenous DFO with, or without deferiprone, remains the currently recommended treatment, in view of its documented ability to salvage these patients.Keywords
This publication has 42 references indexed in Scilit:
- Role of deferiprone in chelation therapy for transfusional iron overloadBlood, 2003
- Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron poolBlood, 2003
- Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: a study in adult patients with acquired anemiasBlood, 2003
- Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overloadEuropean Heart Journal, 2001
- Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia MajorNew England Journal of Medicine, 1994
- Hepatic iron overload: quantitative MR imaging.Radiology, 1991
- Central Venous Catheter InfectionsPediatric Clinics of North America, 1988
- DESFERRIOXAMINE TO IMPROVE CARDIAC FUNCTION IN IRON-OVERLOADED PATIENTS WITH THALASSAEMIA MAJORThe Lancet, 1984
- Iron in the heartThe American Journal of Medicine, 1971
- FERROKINETICS IN MANMedicine, 1970